CTLA-4依存フィードバックループの破壊により,腫瘍に関連したTreg細胞の拡張
Francesco Marangoni1, Ademi Zhakyp2, Michela Corsini3
1The Center for Immunology and Inflammatory Diseases (CIID), Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Medical School, Boston, MA 02115, USA; Department of Physiology and Biophysics, University of California, Irvine, Irvine, CA 92697, USA; Institute for Immunology, University of California, Irvine, Irvine, CA 92697, USA.
Cell
|June 22, 2021
まとめ
Foxp3+ T調節細胞 (Treg) は, dendritic cells (cDCs) と相互作用することによって,腫瘍の耐性を制御する. トレグ細胞はCTLA-4を使って 自身の活性化を制限し 腫瘍の拒絶に不可欠なプロセスです
科学分野:
- 免疫学
- 癌 生物学
- 細胞の相互作用
背景:
- Foxp3+ T調節 (Treg) 細胞は,腫瘍の微小環境 (TME) で免疫的耐性を維持するために不可欠です.
- TME内のTreg細胞の機能と活性化を制御する正確なメカニズムは完全に理解されていません.
研究 の 目的:
- TME内のTreg細胞の活性化と機能を制御する細胞相互作用を調査する.
- 腫瘍におけるTreg細胞数と活性を制御する制御フィードバックループを解明する.
主な方法:
- TME内の細胞相互作用をリアルタイムで視覚化および分析するために,腸内顕微鏡を用いた.
- 腫瘍関連従来の樹状細胞 (cDC) によって提示される抗原のTreg細胞認識の特徴.
- Tレグ細胞の調節と増殖におけるCTLA-4とCD28の役割の評価
主要な成果:
- Treg細胞は,TMEにおけるcDCによって提示される抗原を優先的に認識する.
- 安定した相互作用はTヘルパー細胞を活性化する.
- Treg細胞はCTLA-4を使用して,cDCの共刺激分子をダウン調節し,自身の活性化を制限します.
- CTLA- 4の阻害はTreg細胞の過剰増殖につながり,腫瘍の拒絶のためにTreg細胞の不活性化が必要になります.
結論:
- Treg細胞は,CTLA-4とCD28に依存するフィードバックループを通じて,TME内の集団サイズを自己調節する.
- CTLA-4 阻害によるこのTreg細胞の調節ループの破壊は,がん治療における治療効果を相殺する可能性があります.
関連する概念動画
T Cell Types and Functions
1.6K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.6K
The Tumor Microenvironment
7.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.1K
Tumor Immunotherapy
790
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
790
Cytotoxic T Cells-mediated Immune Response
5.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
5.4K
T Cell Activation and Clonal Selection
12.4K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
12.4K


